Literature DB >> 16281668

Intensive care and invasive ventilation in the elderly patient, implications of chronic lung disease and comorbidities.

C Nielson1, D Wingett.   

Abstract

AIMS: Elderly patients have an increasing prevalence of illness that requires consideration of critical care and invasive ventilatory support. Although critical care of even the very elderly can provide value, with increasing age the potential risks of treatment and diminishing returns with respect to quality and quantity of life result in a need for careful evaluation. Variable combinations of impaired organ function, active disease and residual pathology from past disease and injury all affect critical care, with the consequence that the elderly are a very heterogeneous population. Recognizing that critical care is a limited resource, it is important to identify patients who may be at increased risk or least likely to benefit from treatment. Patients with functional impairments, nutritional deficiencies and multiple comorbidities may be at highest risk of poor outcomes. Those with very severe disease, extreme age and requirements for prolonged ventilatory support have high in-hospital mortality. Functional impairments, comorbidities and severity of illness are usually more important considerations than chronologic age. The objective of this review is to identify how common problems of the elderly affect critical care and decisions concerning use of invasive ventilatory support.

Entities:  

Mesh:

Year:  2004        PMID: 16281668     DOI: 10.1191/1479972304cd012rs

Source DB:  PubMed          Journal:  Chron Respir Dis        ISSN: 1479-9723            Impact factor:   2.444


  2 in total

1.  [Cases and duration of mechanical ventilation in German hospitals : An analysis of DRG incentives and developments in respiratory medicine].

Authors:  A Biermann; A Geissler
Journal:  Anaesthesist       Date:  2016-08-05       Impact factor: 1.041

Review 2.  [Sleep disorders among physicians on shift work].

Authors:  O Schlafer; V Wenzel; B Högl
Journal:  Anaesthesist       Date:  2014-11       Impact factor: 1.041

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.